Literature DB >> 17245763

Calibration and validation of an oral fluid-based sensitive/less-sensitive assay to distinguish recent from established HIV-1 infections.

Anne M Sill1, Kristen Kreisel, Bethany Griffin Deeds, Craig M Wilson, Niel T Constantine, Ligia Peralta.   

Abstract

Sensitive/less-sensitive (S/LS) serum-based serologic methods have been developed to measure human immunodeficiency virus (HIV) incidence by distinguishing recent from established infections. Such methods require venipuncture. The goal of this study was to develop an alternative to serum-based S/LS testing using oral fluid (OF) as the testing medium. Serum/OF pairs were collected from 342 patients attending 15 Adolescent Trials Network (ATN) clinical sites. The sera were tested with the use of the dilutional Vironostika (DV; Biomerieux, Durham, NC) S/LS assay (DV(SOD=1.0)) as the reference against which an OF LS assay was calibrated using 40 of the OF pairs. Receiver operating characteristic (ROC) curve analyses pinpointed the OF LS test parameters that maximized concordance with the serum-based DV. Validation of the calibrated OF LS included testing of the remaining 302 serum/OF pairs. During calibration the maximum concordance with the DV was 95.2% and 89.5% for 21 recent and 19 established samples, respectively, at a 1:50 OF sample dilution and an optical density (OD) cutoff of 0.280. When applied to the validation sample set (N=302), the concordance was 73.6% for the recent samples and 89.6% for the established samples. The OF LS assay showed a good concordance with the serum-based reference S/LS assay. It presents an alternative to invasive specimen collection, and has the potential for increasing test compliance in young subjects. However, because of the uncertainty of the performance characteristics of the serum-based S/LS assay with which it was compared, further validation of the OF LS using seroconversion sample pairs is needed. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17245763      PMCID: PMC6649113          DOI: 10.1002/jcla.20144

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  10 in total

1.  Detecting recent human immunodeficiency virus type 1 infection: why and how?

Authors:  Trudy Dobbs; Bharat S Parekh
Journal:  MLO Med Lab Obs       Date:  2003-05

2.  Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence.

Authors:  Denise Kothe; Robert H Byers; Samuel P Caudill; Glen A Satten; Robert S Janssen; W Harry Hannon; Joanne V Mei
Journal:  J Acquir Immune Defic Syndr       Date:  2003-08-15       Impact factor: 3.731

3.  UNAIDS Reference Group on estimates, modelling and projections--statement on the use of the BED assay for the estimation of HIV-1 incidence for surveillance or epidemic monitoring.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2006-01-27

4.  Evaluation of youth preferences for rapid and innovative human immunodeficiency virus antibody tests.

Authors:  L Peralta; N Constantine; B Griffin Deeds; L Martin; K Ghalib
Journal:  Arch Pediatr Adolesc Med       Date:  2001-07

Review 5.  HIV testing technologies after two decades of evolution.

Authors:  Niel T Constantine; Holly Zink
Journal:  Indian J Med Res       Date:  2005-04       Impact factor: 2.375

Review 6.  Statistical methods in medical diagnosis.

Authors:  C B Begg
Journal:  Crit Rev Med Inform       Date:  1986

Review 7.  Surveillance for incident HIV infection: new technology and new opportunities.

Authors:  G W Rutherford; S K Schwarcz; W McFarland
Journal:  J Acquir Immune Defic Syndr       Date:  2000-12-15       Impact factor: 3.731

8.  Development of a new less-sensitive enzyme immunoassay for detection of early HIV-1 infection.

Authors:  Bhupat D Rawal; Azucena Degula; Ludmila Lebedeva; Robert S Janssen; Frederick M Hecht; Haynes W Sheppard; Michael P Busch
Journal:  J Acquir Immune Defic Syndr       Date:  2003-07-01       Impact factor: 3.731

9.  Improved classification of recent HIV-1 infection by employing a two-stage sensitive/less-sensitive test strategy.

Authors:  Niel T Constantine; Anne M Sill; Noreen Jack; Kristen Kreisel; Jeffrey Edwards; Thomas Cafarella; Harry Smith; Courtenay Bartholomew; Farley R Cleghorn; William A Blattner
Journal:  J Acquir Immune Defic Syndr       Date:  2003-01-01       Impact factor: 3.731

10.  New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes.

Authors:  R S Janssen; G A Satten; S L Stramer; B D Rawal; T R O'Brien; B J Weiblen; F M Hecht; N Jack; F R Cleghorn; J O Kahn; M A Chesney; M P Busch
Journal:  JAMA       Date:  1998-07-01       Impact factor: 56.272

  10 in total
  5 in total

1.  Demographic profiles of newly acquired HIV infections among adolescents and young adults in the U.S.

Authors:  Anne M Sill; Niel T Constantine; Craig M Wilson; Ligia Peralta
Journal:  J Adolesc Health       Date:  2009-07-08       Impact factor: 5.012

Review 2.  Diagnosis of Human Immunodeficiency Virus Infection.

Authors:  Bharat S Parekh; Chin-Yih Ou; Peter N Fonjungo; Mireille B Kalou; Erin Rottinghaus; Adrian Puren; Heather Alexander; Mackenzie Hurlston Cox; John N Nkengasong
Journal:  Clin Microbiol Rev       Date:  2018-11-28       Impact factor: 26.132

Review 3.  Current and future assays for identifying recent HIV infections at the population level.

Authors:  Joanna Smoleń-Dzirba; Tomasz J Wąsik
Journal:  Med Sci Monit       Date:  2011-05

4.  Misclassification of recent HIV-1 seroconversion in sub-Saharan Africa using the sensitive/less sensitive technique.

Authors:  Kwabena O Duedu; Anna A Hayford; Kwamena W Sagoe
Journal:  Virol J       Date:  2011-04-17       Impact factor: 4.099

5.  Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes.

Authors:  Yen T Duong; Reshma Kassanjee; Alex Welte; Meade Morgan; Anindya De; Trudy Dobbs; Erin Rottinghaus; John Nkengasong; Marcel E Curlin; Chonticha Kittinunvorakoon; Boonyos Raengsakulrach; Michael Martin; Kachit Choopanya; Suphak Vanichseni; Yan Jiang; Maofeng Qiu; Haiying Yu; Yan Hao; Neha Shah; Linh-Vi Le; Andrea A Kim; Tuan Anh Nguyen; William Ampofo; Bharat S Parekh
Journal:  PLoS One       Date:  2015-02-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.